Tag Archives: Venture Capital

Hightouch and Snowflake Boost AI-Powered Marketing Data Stack with Snowflake Ventures Investment

Snowflake

Marketing teams are increasingly leveraging AI to deliver differentiated and personalized experiences, and it’s clear this is where the competitive advantage now lies. In fact, nearly 75% of marketers already feel AI gives them an edge, and more than 85% plan to significantly increase their AI adoption in the next two to three years. To achieve and scale high-ROI campaigns, marketing and data teams need better ways to collaborate to unlock and activate strategic insights from their data.

This critical need makes our latest Snowflake Ventures investment in Hightouch, alongside Capital One Ventures, all the more essential. Hightouch is a data and AI platform for marketers that empower enterprises to activate their customer data directly from Snowflake to over 200 destinations, including critical marketing and advertising platforms.

We recently recognized Hightouch’s achievements within the Snowflake AI Data Cloud ecosystem by naming it our 2025 Marketers & Advertisers Data Cloud Product Partner of the Year. Hightouch earned this recognition for helping our joint customers personalize experiences, drive measurable ROI across marketing and advertising channels and activate data at scale.

 

Powering new AI marketing innovations

The combined power of Snowflake and Hightouch delivers a secure, governed data stack for AI-driven marketing. This investment sets the stage for joint development of solutions that will change how marketers operate, including new AI-driven capabilities like Hightouch AI Decisioning – an agentic AI product for lifecycle marketing that runs natively via Snowflake Cortex AI.

These new capabilities, along with support for Snowflake Horizon Catalog — a fully integrated solution for role-based access controls — will make it easier for Hightouch customers to fully adopt Snowflake as their AI Data Cloud. This provides frictionless access to native security, governance and advanced AI features not available on other data platforms. This will also simplify the adoption of Hightouch for Snowflake customers, enabling them to easily leverage its AI-powered marketing solutions to drive personalization at scale.

 

Real-world impact with AI

Hundreds of customers are already using Hightouch as their Composable CDP and AI marketing solution with Snowflake as the single source of truth for all customer, marketing and enterprise data, including:

  • WHOOP: The marketing team at WHOOP uses Hightouch and Snowflake Cortex AI to maximize customer lifetime value through AI-powered personalization. This enables them to break free from the constraints of rule-based marketing and take personalization efforts beyond human scale, using AI to autonomously experiment and optimize every customer interaction.
  • Warner Music Group (WMG): WMG’s music publishing company, Warner Chappell Music, has more than 1 million copyrights in its catalog. By building a consumer intelligence platform with Snowflake and Hightouch, WMG now leverages data to “super-serve” fans, artists and brands. This has helped them increase efficiency with streamlined audience creation and syndication, as well as accelerate data-driven collaboration and innovation.
  • Accor: The global hospitality group implemented a Composable Customer Data Platform (CDP) using Snowflake and Hightouch to improve customer segmentation and personalized marketing. This system reduced campaign preparation time from three weeks to two days, enhanced data-driven marketing for more effective targeting and optimized budgets, and laid the groundwork for future AI integration for deeper customer insights.

What’s next for Hightouch and Snowflake

The future of AI-driven marketing with Hightouch and Snowflake is incredibly exciting. We envision AI decisioning rapidly evolving to train on all data types — structured and unstructured — accessed directly within Snowflake, fundamentally transforming creative strategies. Expect to see dedicated, industry-specific solutions emerge across retail, financial services, healthcare/life sciences and media and entertainment, bringing bespoke AI power to every sector.

Learn how leading marketers across industries are using the Snowflake AI Data Cloud to unify their customer, marketing and enterprise data.

Categories: News

Tags:

ICOS Capital invests in Dutch bio-based resin and materials company Plantics B.V. to accelerate scale up

Icos Capital

ARNHEM, Netherlands, June 26, 2025 – ICOS Capital has announced a minority equity investment in the privately-owned Dutch company Plantics B.V. The financing by ICOS Capital will provide Plantics with resources to accelerate commercial roll-out, scale up production capacity and increase the number of new product applications.

The strategy of ICOS is to accelerate sustainability by investing in breakthrough technologies with proven scalability and clear market traction. ICOS Capital is headquartered in Amsterdam. Next to ICOS Capital, the regional investment company Oost NL as well as Nationaal Groenfonds (The Dutch National Fund for Green Investments) joined ICOS in this investment round. Nova by Saint-Gobain, the venture arm of Saint-Gobain, worldwide leader in light and sustainable construction, already completed their investment and collaboration agreement in 2024.

Peter van Gelderen, general partner of ICOS, quotes: “We are very pleased to invest in Plantics at this important moment. Plantics is an internationally recognized pioneer in sustainable bio-based material technologies. Currently the company is scaling up its capacity to meet growing customer demands. In this growth phase we can really add value to the company.”

Wridzer Bakker, CEO of Plantics adds: “After Saint-Gobain last year, we are very proud to onboard another top professional shareholder. Plantics fits very well in the investment profile of ICOS as our company has a sustainable competitive advantage and contributes to the reduction of CO2 emissions. ICOS will provide us with financing, hands-on support and access to their network.”

 

About ICOS Capital ICOS brings together fast growth innovators with sector leading corporations to facilitate growth with deep financing, engineering and production expertise, infrastructure and market access. Learn more by visiting www.icoscapital.com.

About Plantics B.V. Plantics builds on a revolutionary invention resulting in a unique group of 100 percent biobased circular thermoset resins and the world’s first 100 percent biobased circular thermoset materials. Recognized as one of the most promising biomaterials companies, Plantics, together with its partners, develops high-quality, circular and CO2 negative products. Learn more by visiting www.plantics.com.

Categories: News

Tags:

Introducing Mandolin: AI Teammates for Healthcare

Introducing Mandolin: AI Teammates for Healthcare

When we first met Will Yin and Rohit Rustagi, it was clear that they were obsessed with solving an urgent problem in healthcare: closing the time-to-access for specialty therapies that treat conditions like cancer and Alzheimer’s.

In our meeting, Will articulated how he could build “a new kind of worker for healthcare.” One that could log in, pick up the phone, fill out a form, and ultimately help patients get access to specialty pharmaceuticals in a fraction of the time.

It was an idea rooted in experience. Both Will and Rohit had family members struggle to access specialty therapies for conditions like cancer and Alzheimer’s — the types of drugs that cost hundreds of thousands of dollars and take weeks or months to approve (if they’re approved at all). These are powerful, personalized therapies, but the workflows to deliver them are stuck in the past. Clinics, health systems, and pharmacies lose weeks navigating approvals, reading policy documents, and chasing reimbursement — all while patients wait for treatment.

And the problem is only growing. Specialty drugs now account for over half of U.S. prescription spend and are 75% of the FDA drug pipeline. The healthcare system can’t keep up.

Mandolin is solving for this, with its AI automation platform for specialty drug access. We at Greylock are privileged to partner with Will and Rohit and lead the company’s Series A investment.

Mandolin’s AI agents act like full-time employees — reading, reasoning, and completing tasks across systems. From benefits verification to prior auth and billing, it’s not a tool but a workforce. One that works 24/7, scales effortlessly, and delivers higher accuracy than traditional workflows.

And it’s working. Since launching their agents in January, Mandolin is already live with some of the largest infusion providers, specialty pharmacies, and health systems in the country, including Vivo, FlexCare, OI Infusion, and TwelveStone. It’s deployed at 700+ clinics and serves over 250,000 new patients annually. Teams are cutting days of administrative work down to hours, increasing revenue, reducing manual overhead, and getting patients on therapy weeks sooner than before.

Some of the most thoughtful founders we’ve worked with didn’t initially set out to build companies, but encountered a problem they just had to solve. Will spent his high school and college years publishing neuroscience research and preparing for a career as a physician-scientist. Rohit, a Fulbright awardee, studied bioethics and entered med school at Stanford. They each walked away from medicine — not because they lost faith in science, but because they realized the real bottleneck was the system and the timing was right to make a real impact.

The emergence of multi-agent AI platforms finally has the tooling to automate complex workflows end-to-end. As Mandolin builds the definitive AI teammate for the largest health systems in the world, we’re proud to support Will, Rohit, and team as they turn AI into a force that helps more people access the care they need, when they need it. If you’re interested in this mission, Mandolin is hiring!

Categories: News

Tags:

Diskover, Backed by Snowflake Ventures, Empowers Enterprises with Full Visibility into Their Legacy Data Estates

Snowflake

A successful AI strategy requires a solid data foundation, yet a striking number of data and AI leaders are feeling unprepared. According to a survey of executives, a quarter described their data foundations as “somewhat unready” to “very unready” to support generative AI applications, and more than half admit they are only “somewhat ready.”

Compounding this challenge, enterprises are grappling with petabytes of data trapped on legacy storage devices. The lack of visibility into these systems makes it impossible to search for or identify critical information and can cost companies with 100 employees dealing with data around $2.7 million dollars annually. Diskover is at the forefront of tackling this challenge by helping customers find, analyze and enrich data for smart decision-making and quick action — from everyday tasks to advanced AI and data lake applications.

The ability to unlock the value of scattered, unstructured data through global visibility is a key reason we are supporting Diskover through an investment from Snowflake Ventures. Our investment enables a seamless process for our joint customers to identify the most valuable data and enable developers to ingest that data into Snowflake using Snowflake Openflow without rearchitecting or setup.

Customers will be able to access Diskover via Snowflake Marketplace to get better visibility of their data across disparate storage systems such as NetApp, Dell EMC, Vast and DDN, all within their Snowflake environment. Looking ahead, once customers identify critical data using Diskover, they’ll be able to seamlessly replicate it to Snowflake using Openflow, and Diskover is developing the direct connectors to enable customers to do all this from the Diskover interface.

Diskover helps companies pinpoint their most valuable data across legacy storage appliances by delivering a unified view of all of an organization’s data, offering global visibility and searchability and providing features to enhance overall data efficiency. Combined with the power of Snowflake’s easy, trusted and connected platform, our integration will help customers effortlessly ingest their most essential data, bringing clarity and real operational value to build a robust data foundation ready for AI.

Stay tuned to try Diskover Data’s Snowflake connected app, available soon in Snowflake Marketplace.

Categories: News

Tags:

Rabo Investments invests in community platform Area of People

Rabo Investments

Utrecht, June 12, 2025 — Rabo Investments has acquired a strategic minority stake in Area of People, a Dutch scale-up in the real estate market.

Area of People offers an AI-driven community platform that enables real estate developers, investors, and housing associations to actively collaborate and contribute to social cohesion. The platform measures social impact in real time and automatically generates targeted advice to enhance residential well-being. This leads to more connected living and working environments that are not only more livable but also offer sustainable long-term value. The investment from Rabo Investments will be used for product development and the commercial rollout of the platform. In addition to this investment, Rabobank will support the further development of market standards for ESG reporting and loans that promote social impact.

The Dutch housing market faces major challenges. Affordability, sustainability, and community resilience require innovative solutions. As a result, real estate players are shifting from individual, labor-intensive services to smart, scalable collaboration with and for communities. A digital platform like Area of People plays a key role in this transition.

Joan Ronner, co-founder and CEO of Area of People, said: “This partnership is an important milestone for us. Rabo Investments shares our vision that social sustainability must be an integral part of real estate development, and will therefore collaborate with us in further product development. Thanks to their support, we can increase our impact and contribute to a future where every neighborhood is a community.”

“With this investment, we underline our thematic and cooperative approach, where we aim to create both financial and strategic value for the bank and our clients,” said Martijn Scholtes, Head of Corporate Venturing at Rabo Investments. “Area of People offers a scalable and data-driven solution that perfectly aligns with our vision of a future-proof housing market in which social sustainability and financial well-being play a central role.”

Area of People was founded in 2018 and now serves over 70 clients at more than 270 locations across the Netherlands. In 2021, Lenos Equity also acquired a minority stake.

Categories: News

Tags:

XRobotics’ raises $2.5M as countertop robots cooks up 25,000 pizzas a month

SOSV

In the fast-paced world of food service, speed and consistency can make or break a business. That’s why XRobotics believes it’s cracked the code on how to bring robotics into everyday restaurants – starting with pizza. And they’ve just announced a $2.5 million seed round led by FinSight Ventures with participation from SOSV, MANA Ventures, and Republic Capital.

The San Francisco-based company has built a compact countertop robot called the xPizza Cube. About the size of a stackable washing machine, the device uses ML to apply sauce, cheese, and pepperoni to pizza dough with speed and precision. It can crank out up to 100 pizzas per hour and adapt to a variety of styles, including Chicago deep dish and Detroit square.

The economics are compelling: the machine leases for $1,300/month over three years and retrofits into existing kitchens, making it accessible to national chains as well as mom and pop shop owners.

“This saves almost 70, sometimes 80% of the time for the staff,” says co-founder and CEO Denis Rodionov. “It is just repeatable work. If you have a pepperoni pizza, you need to place 50 slices of pepperoni one by one.” The robot does that for you, perfectly, every time.

Kira Colburn

READ COMPLETE ARTICLE

Categories: News

Tags:

Our Investment in Cursor – accel

Accel

We’re pleased to announce our investment in Cursor, the company shaping the future of software engineering. What Michael, Aman, Arvid, and Sualeh have accomplished in just a few short years is without precedent, and it’s clear they’re only getting started.

As software has accelerated every company and industry over the past several decades, tools supporting engineering teams have flourished – yet astonishingly, the process of writing code itself has hardly changed. Cursor shrinks the gap between human intent and action.  We believe it will become the collaborative interface between humans and computers, where every keystroke, action or inaction is an exchange of information that helps to accelerate cycles and achieve better outcomes. With relentless execution and distinctive product taste, the Cursor team is making software engineering a seamless extension of the human brain.

With over $1.5 billion invested in AI-native companies, we have observed the compounding leadership effect of winners in certain categories. In coding, developer choice —> wider distribution & deeper engagement —> higher fidelity keystroke data —> compounding product differentiation. With market leadership comes disproportionate access to talent, capital, GPU capacity, and marketplace influence.

The future is uncertain, but it will likely involve various configurations of humans and agents writing code together.  Today, Cursor changes the paradigm for building software; tomorrow, we believe it will be the operating system for human-machine collaboration across all developers.  We’re delighted to back Michael and this incredibly talented team for the ambitious journey ahead.

Categories: News

Tags:

Congratulations, Circle! – Accel

Accel

Today marks an exciting milestone for Jeremy Allaire and the Circle team as they go public. For those of us who have watched this journey up close, this is a milestone years in the making—and a testament to Jeremy and the Circle team’s persistence.

This isn’t Jeremy’s first time on the podium. He last rang the bell when he took Accel portfolio company Brightcove public in 2012. With Circle, he took on his next challenge: launching a company with the ambitious goal of building a new digital financial system in an industry characterized by complexity, intense public scrutiny, and regulatory uncertainty. It turns out that Jeremy and his team were more than up to the task.

Circle was founded in 2013 with a broad vision to facilitate the next stage of internet-driven globalization and commerce. Today, USDC—Circle’s stablecoin—has become one of the most widely used digital currencies in the world, with more than $25 trillion in on-chain transactions as of late March.

What stands out about the Circle team is their willingness to take the long view, even when it means doing things the hard way—in particular, through their commitment to a regulatory-first posture and their reputation for integrity and transparency.

Congratulations to Jeremy and everyone at Circle!

–The Accel Team

Categories: News

Tags:

Rabo Investments sells stake in Dutch high-tech healthcare manufacturer IGS GeboJagema to BC Partners

Rabo Investments

BC Partners to invest in IGS Gebojagema in partnership with Management and Smile Invest

Rabo Private Equity exits after supporting IGS’s international growth alongside Smile Invest

June 4 2025 – IGS GeboJagema (“IGS”), the leading independent pure-play healthcare manufacturer in the tooling market, announces, together with its current financial partner Smile Invest and management, a new strategic partnership with BC Partners, a leading international investment firm.

As part of the transaction, BC Partners will acquire a majority stake in the business alongside current financial partner Smile Invest and the IGS management team, who will retain a minority shareholding. Rabo Investments, which previously held a minority stake, will fully exit the business.

IGS is headquartered in Eindhoven, the Netherlands, with a growing presence in the United States through its facility in Peachtree City, Georgia. The business designs, manufactures and services complex, high-precision moulds used in the production of critical medical devices, including drug delivery systems, contact lenses, diagnostic equipment and healthcare consumables. With decades of specialised expertise, IGS has built a strong reputation as a global leader, in the supply of mission-critical tooling to the world’s leading healthcare and pharmaceutical companies. IGS is poised to write its next chapter of growth by building on its exceptional market position, expanding its presence in the rapidly growing GLP-1 segment and entering new healthcare end-markets that demand high-precision moulds.

IGS identified BC Partners as its strategic partner of choice that shares its values, long-term vision, and dedication to excellence in healthcare. BC Partners brings extensive experience in backing resilient, high-growth companies, particularly in pharma and specialised manufacturing. BC Partners’ track record through its investments in Aenova, IMA, Synthon, and Pharmathen demonstrate its deep expertise in pharma and healthcare automation and ability to support innovation, internationalisation, and operational scale.

This partnership aims to build on IGS’ strong foundations and accelerate its next phase of growth – through continued investment in organic expansion, targeted M&A opportunities, and entry into adjacent verticals. Just as importantly, it reflects a shared commitment to empowering IGS’ talented team and securing the long-term future of the business.

IGS and its shareholders were advised by Rothschild & Co (M&A adviser).

The transaction is subject to receipt of customary regulatory approvals and workers council feedback.

 

Herman Rusch – CEO, IGS GeboJagema

“Partnering with BC Partners marks an exciting new chapter for IGS. Their investment is a strong recognition of the expertise, innovation, and commitment that our team has demonstrated in becoming a global leader in precision mould manufacturing for the medical industry. BC Partners brings a deep understanding of the healthcare and specialised manufacturing sectors, and their experience with businesses like Aenova, IMA, Synthon and Pharmathen makes them an ideal partner for our next phase of growth.

We are deeply thankful to Smile Invest for the close collaboration and continued partnership, and to Rabo Private Equity for their support over the past years. Together, we’ve laid a strong foundation for the future. With BC Partners now joining us, we look forward to building on that momentum – expanding our capabilities, entering new healthcare markets, and continuing to support our customers in delivering high-quality medical solutions that make a real difference in patients’ lives.”

Matthew Evans – Managing Director, BC Partners

“We are excited to partner with Smile and the whole team at IGS to keep building the company and invest in new capabilities and avenues for further expansion. None of this would be possible without the impressive foundation that has been built over the years, by the IGS team past and present, and by Smile and Rabo. We look forward to continuing to deepen IGS’ partnership with its existing customers, while also introducing new partners across the globe to the quality and sophistication of IGS.“

Bart Cauberghe – Managing Partner and Ad Notenboom – Partner, Smile Invest

“Supporting the growth journey of IGS over the past years has been a highly rewarding experience. In that time, the company has reinforced its position as a global leader in precision moulds for the medical device industry, expanded its international footprint to the US, and continued to deliver exceptional quality and innovation to its customers . We are pleased to welcome BC Partners as a like-minded investor with a strong track record in healthcare. Together with BC Partners and the IGS management team, we look forward to supporting the next phase of growth and value creation.”

Bas Verlee – Director and Roelant Mantel – Director, Rabo Investments

“It has been a privilege to support IGS over the past years and invest alongside management and Smile Invest. We’re proud to have contributed to their impressive growth journey, and, with BC Partners now joining, we’re confident IGS is in excellent hands for the future.”

 

IGS GeboJagema

IGS GeboJagema (“IGS”) is the global leading, pure-play healthcare, high-precision mould technology provider. As the largest pure-play healthcare manufacturer, leveraging Industry 4.0 technologies, IGS produces high-precision, ultra-low tolerance, multi-cavity injection moulds that enable exact, repeatable, and scalable production of medical devices. IGS serves as a key strategic partner to leading global pharmaceutical and healthcare companies, particularly in the drug delivery and ophthalmology segments, while actively expanding into diagnostics and healthcare consumables. Founded in 1945, IGS is headquartered in Eindhoven, the Netherlands, and has a growing presence in the United States through its facility in Peachtree City, Georgia. The company employs approximately 174 FTEs.

Smile Invest

Smile Invest (Smart Money for Innovation Leaders) is a European evergreen investment firm with over €500m of assets under management, financed by 40 entrepreneurial families and with a long-term focus on innovative growth companies. Smile Invest focuses on companies active in three investment themes: Advanced technologies, Innovative Healthcare and Environment. Since its inception in 2017, Smile Invest has invested in 19 platform companies in Belgium and the Netherlands. From its offices in Leuven and The Hague, the team supports ambitious entrepreneurs and management teams in realising their growth plans.

Rabo Private Equity

Rabo Private Equity (“RPE”) is part of the captive investment arm of Rabobank with a €3.5 billion mandate, dedicated to supporting companies that drive innovation in Food & Agriculture and Energy. As a long-term investor, RPE leverages its global network, expertise, and dedicated teams to create value and accelerate key transitions for a better world. By partnering with visionary teams, RPE aims to build resilient businesses that contribute positively to society and the planet.

BC Partners

BC Partners is a leading investment firm with circa €40 billion in assets under management across private equity, private debt, and real estate strategies. Established in 1986, BC Partners has played an active role for over three decades in developing the European buy-out market. Today BC Partners integrated transatlantic investment teams work from offices in Europe and North America and are aligned across our four core sectors: TMT, Healthcare, Services & Industrials, and Consumer. Since its foundation, BC Partners has completed over 128 private equity investments in companies with a total enterprise value of over €170 billion and is currently investing its eleventh private.

Categories: News

Tags:

Emerald Invests in Cajo Technologies, Sustainable Laser Marking Leader

Emerald

Kempele, Finland / Zurich, Switzerland – Cleantech venture capital pioneer Emerald Technology Ventures has announced an investment  in Cajo Technologies, a Finnish provider of advanced laser marking solutions. The round will accelerate Cajo’s growth and allow them to commercialize the groundbreaking  MakeBright™  marking technology for  packaging.

Advancing Sustainable Packaging Solutions

Cajo has developed and patented technologies that eliminate the need for consumables such as ink, labels, or adhesives, significantly lowering the environmental footprint of product marking. Their technology allows for the direct marking on a wide array of

Their MakeBright™  marking technology is a revolutionary new way to produce precise and permanent product markings on cardboard more sustainably, without additives like ink, glue, ribbons, or labels. This eases the recycling process and enables cost savings.

The Growing Need for Sustainable Packaging Marking

Cajo’s solutions cater to forward-thinking stakeholders in the industry looking to significantly improve production processes while lowering operational costs. Cajo’s solutions are already trusted by major industrial players across diverse sectors—including PepsiCo, SSAB, Fiskars, and Prysmian for applications ranging from primary and secondary packaging to metal, wire, and cable marking.

Capturing a High-Growth Market

The global laser marking market is forecasted to exceed EUR 4 billion by 2027, driven by increasing regulatory demands, anti-counterfeit measures, and the need for supply chain traceability. Cajo is well-positioned within this market with its scalable product portfolio—ranging from Integrable marking units to turnkey industrial systems—and its proprietary software platform.

Supporting Next-Stage Growth

With Emerald’s investment and strategic support, Cajo plans to scale commercial operations, expand internationally—particularly in Asia and North America—and advance its customer success, R&D, and production capabilities.

“We are thrilled to partner with Cajo to accelerate the transition to sustainable marking technology” said Fredric Petit, Partner at Emerald. “Cajo’s technology is not only a powerful enabler of traceability and eco-efficiency but also commercially validated by global industry leaders.”

Niko Karsikas, CEO of Cajo Technologies, added, “Emerald’s industrial network and deep expertise in scaling cleantech ventures make them an ideal partner for our next chapter. With their support, we are set to deliver impactful solutions to the global packaging and industrial sectors.”

More on sustainable packaging and materials at Emerald:

Emerald leads €6.2M investment in Vytal to fuel the reusable packaging revolution

Emerald client, SIG, invests into coating manufacturer Kalpana

How Innovation in the Field of Plastic Additives is Key for a Circular Economy

About Emerald Technology Ventures

Emerald is a globally recognized venture capital firm, founded in 2000, that manages and advises assets of over €1 billion from its offices in Zurich, Toronto and Singapore. The firm invests in start-ups that tackle big challenges in climate change and sustainability, with four current funds, hundreds of venture transactions and five third-party investment mandates, including loan guarantees to over 100 start-ups.

This is Emerald.

Bold Ideas. Bright Future.  www.emerald.vc

CONTACT FOR EMERALD:

info@emerald.vc

About Cajo Technologies

Cajo Technologies: Pioneering Sustainable Product Marking

In an era where sustainability is a key driver of industrial innovation, Finnish SME Cajo Technologies Ltd. is revolutionizing product marking with its patented laser solutions. By eliminating the need for ink, labels, and chemicals, Cajo provides an eco-friendly and cost-efficient alternative to traditional marking methods.

Headquartered in Kempele, Finland, with subsidiaries in India, Cajo Technologies is rapidly expanding its global presence. The company offers comprehensive, easy-to-use solutions for traceability and product marking, leveraging proprietary software and patented technology. Fully optimized for industrial production, Cajo’s marking solutions seamlessly integrate into existing manufacturing processes, significantly reducing maintenance and operational costs.

Beyond efficiency, Cajo’s technology ensures high-precision traceability markings, even in the harshest industrial environments, while reducing the carbon footprint by up to 90%. This sustainable alternative allows companies to eliminate consumables and harmful additives from their production, aligning with the growing demand for zero-waste manufacturing solutions.

With a trusted presence in over 80 countries and partnerships with global industry leaders, Cajo Technologies is setting a new benchmark in sustainable manufacturing. By combining innovation with environmental responsibility, the company demonstrates that sustainability and profitability can go hand in hand.

Choose Cajo for intelligent product marking.

CONTACT FOR CAJO:

info@cajotechnologies.com

 

Categories: News

Tags: